Two Sigma Investments, LP Repligen Corp Put Options Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $3.89 Million - $4.78 Million	15,700 Added 307.84%	20,800 $5.51 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $1.19 Million - $1.98 Million	-6,100 Reduced 54.46%	5,100 $1.47 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $1.66 Million - $2.21 Million	10,000 Added 833.33%	11,200 $2.24 Million
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $234,481 - $294,138	-1,300 Reduced 52.0%	1,200 $233,000
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $306,275 - $395,675	2,500 New	2,500 $369,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.